Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26367 | 20580331 | Dig Liver Dis | Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
| A26368 | 20580037 | Metabolism | Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26369 | 20579864 | J Nutr Biochem | Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. | 2010 | Details |
| A26372 | 20576005 | Obes Rev | Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? | 2011 | Details |
| A26376 | 20569523 | Proc Nutr Soc | The importance of fatty liver disease in clinical practice. | 2010 | Details |
| A26377 | 20567026 | J Lipid Res | Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. | 2010 | Details |
| A26379 | 20561029 | Eur J Clin Invest | Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. | 2010 | Details |
| A26380 | 20560816 | Scand J Gastroenterol | A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. | 2010 | Details |
| A26383 | 20556538 | Obes Surg | Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence? | 2010 | Details |
| A26385 | 20554486 | Dig Liver Dis | Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease. | 2010 | Details |
| A26386 | 20553760 | Prog Lipid Res | Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. | 2010 | Details |
| A26389 | 20546964 | J Hepatol | The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. | 2010 | Details |
| A26390 | 20537997 | Gastroenterology | Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. | 2010 | Details |
| A26392 | 20531349 | Int J Obes (Lond) | Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. | 2010 | Details |
| A26393 | 20531177 | Curr Opin Clin Nutr Metab Care | Nonalcoholic fatty liver disease in children. | 2010 | Details |
| A26395 | 20529259 | BMC Gastroenterol | Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. | 2010 | Details |
| A26400 | 20518077 | World J Gastroenterol | Soft drinks consumption and nonalcoholic fatty liver disease. | 2010 | Details |
| A26401 | 20513351 | Biochem Biophys Res Commun | Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. | 2010 | Details |
| A26404 | 23148155 | Ther Adv Endocrinol Metab | Advances in the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A26405 | 22444262 | Animal | Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. | 2010 | Details |
| A26406 | 20507559 | Nutr J | Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. | 2010 | Details |
| A26413 | 20498498 | Postepy Hig Med Dosw (Online) | [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease]. | 2010 | Details |
| A26414 | 20497147 | Aliment Pharmacol Ther | Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26418 | 20492324 | J Gastroenterol Hepatol | A fresh look at NASH pathogenesis. Part 1: the metabolic movers. | 2010 | Details |
| A26420 | 20490316 | J Clin Biochem Nutr | A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. | 2010 | Details |
| A26422 | 20485253 | Minerva Gastroenterol Dietol | Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26425 | 20477484 | Biomark Med | Can nonalcoholic steatohepatitis be diagnosed without liver biopsy? | 2009 | Details |
| A26428 | 20473151 | Curr Opin Clin Nutr Metab Care | Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation. | 2010 | Details |
| A26429 | 20472517 | Dig Liver Dis | Relationship between white blood cell count and nonalcoholic fatty liver disease. | 2010 | Details |
| A26437 | 20460921 | Dig Dis | Endocannabinoids and their role in fatty liver disease. | 2010 | Details |
| A26439 | 20460919 | Dig Dis | Animal models of non-alcoholic steatohepatitis: of mice and man. | 2010 | Details |
| A26440 | 20460918 | Dig Dis | PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer. | 2010 | Details |
| A26441 | 20460917 | Dig Dis | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | 2010 | Details |
| A26443 | 20460915 | Dig Dis | Bile acids as regulators of hepatic lipid and glucose metabolism. | 2010 | Details |
| A26445 | 20460913 | Dig Dis | The role of non-alcoholic fatty liver disease in cardiovascular disease. | 2010 | Details |
| A26446 | 20460912 | Dig Dis | Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. | 2010 | Details |
| A26448 | 20460910 | Dig Dis | Chemokines as immune mediators of liver diseases related to the metabolic syndrome. | 2010 | Details |
| A26449 | 20460909 | Dig Dis | Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. | 2010 | Details |
| A26450 | 20460908 | Dig Dis | The role of cytokines in non-alcoholic fatty liver disease. | 2010 | Details |
| A26451 | 20460907 | Dig Dis | Environmental and genetic determinants of fatty liver in humans. | 2010 | Details |
| A26453 | 20460905 | Dig Dis | Epidemiology of non-alcoholic fatty liver disease. | 2010 | Details |
| A26454 | 20459941 | S Afr Med J | Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis. | 2010 | Details |
| A26455 | 20459722 | BMC Public Health | Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. | 2010 | Details |
| A26459 | 20456209 | Int J Clin Pract | Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus. | 2010 | Details |
| A26463 | 20448542 | Obesity (Silver Spring) | Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. | 2010 | Details |
| A26465 | 20441224 | J Proteome Res | Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. | 2010 | Details |
| A26466 | 20435456 | J Nutr Biochem | Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats. | 2011 | Details |
| A26468 | 20432259 | Hepatology | Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. | 2010 | Details |
| A26469 | 20432253 | Hepatology | Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. | 2010 | Details |
| A26471 | 20426802 | Lipids Health Dis | The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26472 | 20423748 | Metabolism | Plasma metabolomic profile in nonalcoholic fatty liver disease. | 2010 | Details |
| A26473 | 20422882 | Hepatogastroenterology | Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD. | 2010 | Details |
| A26477 | 20415840 | Aliment Pharmacol Ther | Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. | 2010 | Details |
| A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26479 | 20414104 | Blood Press Monit | Aortic elastic properties in nonalcoholic fatty liver disease. | 2010 | Details |
| A26480 | 20413174 | J Hepatol | Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. | 2010 | Details |
| A26483 | 20388946 | J Physiol Pharmacol | Therapy of nonalcoholic fatty liver disease: current status. | 2009 | Details |
| A26485 | 20407430 | Am J Gastroenterol | A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. | 2010 | Details |
| A26489 | 20402293 | Coll Antropol | Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity. | 2010 | Details |
| A26493 | 20398645 | Clin Biochem | Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. | 2010 | Details |
| A26496 | 20392873 | J Clin Endocrinol Metab | Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. | 2010 | Details |
| A26499 | 20392512 | J Hepatol | Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. | 2010 | Details |
| A26502 | 20388084 | Curr Pharm Des | Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. | 2010 | Details |
| A26503 | 20387643 | Ukr Biokhim Zh (1999) | Nonalcoholic fatty liver disease: biochemical and therapeutic considerations. | 2010 | Details |
| A26507 | 20379797 | Obes Surg | The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. | 2010 | Details |
| A26509 | 20375640 | Korean J Hepatol | [Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]. | 2010 | Details |
| A26512 | 20372110 | Am J Gastroenterol | Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26516 | 20370678 | Curr Pharm Des | Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. | 2010 | Details |
| A26517 | 20370677 | Curr Pharm Des | Insulin resistance in nonalcoholic fatty liver disease. | 2010 | Details |
| A26519 | 20370674 | Curr Pharm Des | Role of microRNAs in non-alcoholic steatohepatitis. | 2010 | Details |
| A26520 | 20370672 | Curr Pharm Des | Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. | 2010 | Details |
| A26521 | 20370671 | Curr Pharm Des | Current and future therapeutic strategies in NAFLD. | 2010 | Details |
| A26522 | 20370670 | Curr Pharm Des | Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. | 2010 | Details |
| A26524 | 20368747 | Clin Lipidol | Mechanisms and clinical implications of hepatocyte lipoapoptosis. | 2010 | Details |
| A26525 | 20368739 | Nat Rev Gastroenterol Hepatol | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. | 2010 | Details |
| A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
| A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
| A26528 | 20357081 | J Nutr | Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. | 2010 | Details |
| A26529 | 20355234 | World J Gastroenterol | Liver fat content determined by magnetic resonance imaging and spectroscopy. | 2010 | Details |
| A26530 | 20355232 | World J Gastroenterol | Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials. | 2010 | Details |
| A26531 | 20353583 | J Inflamm (Lond) | Elevated endotoxin levels in non-alcoholic fatty liver disease. | 2010 | Details |
| A26533 | 20347174 | J Hepatol | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. | 2010 | Details |
| A26534 | 20308723 | Ann Hepatol | High ghrelin and obestatin levels and low risk of developing fatty liver. | 2010 | Details |
| A26538 | 20303351 | Gastroenterology | Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. | 2010 | Details |
| A26540 | 20300479 | Mediators Inflamm | Inflammatory mediators of hepatic steatosis. | 2010 | Details |
| A26541 | 20299294 | Prim Care Diabetes | Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? | 2010 | Details |
| A26547 | 20227260 | Nutr Metab Cardiovasc Dis | Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. | 2010 | Details |
| A26548 | 20226139 | Zhong Xi Yi Jie He Xue Bao | [Pathogenesis and treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
| A26549 | 20222991 | Lipids Health Dis | NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26552 | 20221393 | PLoS One | Role of alcohol metabolism in non-alcoholic steatohepatitis. | 2010 | Details |
| A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
| A26557 | 20207596 | Dig Liver Dis | From the metabolic syndrome to NAFLD or vice versa? | 2010 | Details |
| A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
| A26564 | 20203061 | Am J Physiol Gastrointest Liver Physiol | Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. | 2010 | Details |
| A26571 | 20189787 | Prostaglandins Leukot Essent Fatty Acids | Fatty liver: role of inflammation and fatty acid nutrition. | 2010 | Details |
| A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
| A26573 | 20186137 | Obesity (Silver Spring) | Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. | 2010 | Details |
| A26574 | 20185414 | J Lipid Res | Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | 2010 | Details |
| A26577 | 20179669 | Int J Obes (Lond) | Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. | 2010 | Details |
| A26578 | 20176643 | Gut | Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. | 2010 | Details |